ARAY - Accuray Incorporated
4.42 0.00 (0.00%)
After hours: 5:05PM EST
| Previous Close | 3.9700 |
| Open | 4.5000 |
| Bid | 4.38 x 4000 |
| Ask | 4.46 x 800 |
| Day's Range | 4.1200 - 4.6100 |
| 52 Week Range | 3.1700 - 6.1500 |
| Volume | 2,938,835 |
| Avg. Volume | 916,322 |
| Market Cap | 383.037M |
| Beta (3Y Monthly) | 1.79 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Motley Fool•52 minutes ago
Why Accuray, Synchrony Financial, and Waters Jumped Today
Market turbulence couldn't stop these stocks from posting sizable gains.
- Motley Fool•6 hours ago
Here's Why Accuray Is Flying Higher Today
Traders cheer a mixed earnings report. Here's what investors need to know.
- Zacks•8 hours ago
Accuray's (ARAY) Q2 Loss Narrows, Radixact Demand Shoots Up
Demand for flagship Radixact & CyberKnife platforms aids Accuray's (ARAY) fiscal Q2 results.
Motley Fool•17 hours agoAccuray Inc (ARAY) Q2 2019 Earnings Conference Call Transcript
ARAY earnings call for the period ending December 31, 2018.
- Thomson Reuters StreetEvents•17 hours ago
Edited Transcript of ARAY earnings conference call or presentation 22-Jan-19 9:30pm GMT
Q2 2019 Accuray Inc Earnings Call
- Motley Fool•5 days ago
Better Buy: Intuitive Surgical vs. Accuray
The third variable discussed is the most important. And there's no question who the winner is there.
- Zacks•8 days ago
Will Accuray (ARAY) Report Negative Earnings Next Week? What You Should Know
Accuray (ARAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.•16 days ago
Read This Before Buying Accuray Incorporated (NASDAQ:ARAY) Shares
We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be remiss not to mention that insider sales have Read More...
- Simply Wall St.•2 months ago
How Should Investors React To Accuray Incorporated’s (NASDAQ:ARAY) CEO Pay?
Joshua Levine became the CEO of Accuray Incorporated (NASDAQ:ARAY) in 2012. This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. Next, we'll consider Read More...
- Zacks•2 months ago
Here's Why You Should Invest in Accuray (ARAY) Stock Now
Accuray's (ARAY) benefits from growing adoption of non-surgical treatment options among cancer patients and increasing demand for its latest offerings.
- Zacks•2 months ago
Are WMGI & ARAY Neck and Neck? Let's Take a Closer Look
Wright Medical (WMGI) scores higher than Accuray (ARAY) when it comes to current-year earnings and growth projections.
- Zacks•3 months ago
Accuray (ARAY) Q1 Loss Wider Than Expected, Gross Orders Rise
Accuray's (ARAY) flagship Radixact System drives Q1 results; strong EBITDA guidance instils hope.
Motley Fool•3 months agoAccuray Incorporated (ARAY) Q1 2019 Earnings Conference Call Transcript
ARAY earnings call for the period ending September 30, 2018.
- Zacks•3 months ago
Accuray (ARAY) Reports Q1 Loss, Tops Revenue Estimates
Accuray (ARAY) delivered earnings and revenue surprises of -16.67% and 0.77%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.•3 months ago
Who Are The Major Shareholders In Accuray Incorporated (NASDAQ:ARAY)?
The big shareholder groups in Accuray Incorporated (NASDAQ:ARAY) have power over the company. Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions Read More...
- Zacks•3 months ago
Varian (VAR) Buys Noona to Boost Oncology Software Services
Varian's (VAR) latest move provides it significant exposure to the cloud-based oncology services market.
- Zacks•3 months ago
Accuray's (ARAY) Radixact System Used First Time in Germany
Accuray's (ARAY) flagship radiotherapy systems have lucrative prospects.
- Zacks•4 months ago
Accuray's CyberKnife Manages Prostate Cancer Effectively
Accuray's (ARAY) flagship CyberKnife is the only robotic radiotherapy system.
- Simply Wall St.•4 months ago
A Look At The Fair Value Of Accuray Incorporated (NASDAQ:ARAY)
How far off is Accuray Incorporated (NASDAQ:ARAY) from its intrinsic value? Using the most recent financial data, I am going to take a look at whether the stock is fairlyRead More...
Market Realist•5 months agoHere’s What Varian Medical Systems’ Valuation Trend Indicates
In August, nine analysts are covering Varian Medical Systems (VAR) stock. Three of them have given the stock a “strong buy” rating, three have given it a “hold,” and three have given it a “sell.” The mean rating for VAR stock is 2.67 with a target price of $122. That implies an upside potential of 9.1% over its closing price of $111.83 on August 20.
- Motley Fool•5 months ago
Why Zoe's Kitchen, America's Car-Mart, and Accuray Jumped Today
On a positive day for the markets, see why these three stocks outpaced the rest.
- Motley Fool•5 months ago
Why Accuray Is Soaring Today
Shares pop after the company reports upbeat fourth-quarter results. Here's what investors need to know.
- Zacks•7 months ago
Accuray's Radixact Gets AERB Nod in India, Prospects Solid
The Atomic Energy Regulatory Board (AERB) approves Accuray's (ARAY) Radixact X9 in India; exposes the company to AI and Mechatronic trends.
- Simply Wall St.•7 months ago
At US$04.325, Is It Time To Buy Accuray Incorporated (NASDAQ:ARAY)?
Accuray Incorporated (NASDAQ:ARAY), a medical equipment company based in United States, received a lot of attention from a substantial price movement on the NasdaqGS over the last few months, increasingRead More...
- Zacks•7 months ago
New Strong Sell Stocks for June 11th
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
